Statistics showing the number of prescriptions filled in 2011 are astronomically high. See what prescriptions are topping the list.

Indian pharmaceutical company Cipla wins the right to manufacture a cheaper variant of the lung cancer drug ‘Tarceva’ which Swiss firm Roche had contested violated patent laws.

A new weight management supplement has been developed based on research done at the University of Tennessee, Knoxville.

Pluristem Therapeutics’ patented PLX stem cells have saved yet another life of a person with bone marrow failure.

The FDA announced it has given its approval for Zaltrap (ziv-aflibercept) for use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.

A UK study has shown that the use of a “polypill”, filled with 4 different medicines, has the potential to save thousands of lives

The FDA announced its approval for a new anti-obesity drug.

Researchers have sequenced a child’s DNA from a sample of mother’s blood. This instance of non-invasive DNA testing is a major breakthrough because it doesn’t need either fetal samples or the father’s DNA.

Researchers at the Mayo Clinic have linked severe gastrointestinal issues to a commonly prescribed blood pressure drug called Olmesartan, brand name Benicar.